Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia

Bacterial pneumonia remains a significant cause of patient morbidity and mortality worldwide. Pulmonary surfactant serves to maintain homeostasis in the lung through the maintenance of alveolar stability and the regulation of the alveolar immune response. The purpose of this study was to characterize the lung injury and associated surfactant alterations in a rat model of acute Pseudomonas aeruginosa pneumonia. Pneumonia was induced in male Sprague-Dawley rats via intratracheal injection of 0.2 ml, phosphate-buffered saline (PBS) containing P. aeruginosa (6x10(8) colony-forming units x mL(-1)). Control animals received 0.2 mL sterile PBS. Twenty-four hours after inoculation, the pneumonia group (PN) exhibited clinical signs of pneumonia including deficits in gas exchange, leukopenia and elevated arterial lactate levels. Morphological assessment confirmed the presence of pneumonia with airspaces filled with polymorphonuclear cells. Lung homogenate analysis demonstrated evidence of bacterial colonization of pneumonic lung tissue. Lung compliance was also significantly lower in the PN group. Lung lavage analysis of PN rats revealed the pooled surfactant levels to be lower and the surfactant function reduced compared to control rats. Surfactant composition was also found to be altered in PN rats. These results demonstrate that in Pseudomonas aeruginosa pneumonia, the pulmonary surfactant system is both poorly functioning and reduced in quantity. These alterations may contribute to the lung dysfunction characteristic of this disorder.

This article has been cited by other articles:

				N. Soni and P. Williams Positive pressure ventilation: what is the real cost? Br. J. Anaesth., October 1, 2008; 101(4): 446 - 457. [Abstract] [Full Text] [PDF]

				F. C. Henderson, O. L. Miakotina, and R. K. Mallampalli Proapoptotic effects of P. aeruginosa involve inhibition of surfactant phosphatidylcholine synthesis J. Lipid Res., October 1, 2006; 47(10): 2314 - 2324. [Abstract] [Full Text] [PDF]

				J. F. Alcorn and J. R. Wright Degradation of Pulmonary Surfactant Protein D by Pseudomonas aeruginosa Elastase Abrogates Innate Immune Function J. Biol. Chem., July 16, 2004; 279(29): 30871 - 30879. [Abstract] [Full Text] [PDF]

				H. Wissel, C. Schulz, M. Rudiger, M. Krull, P. A. Stevens, and R. R. Wauer Chlamydia pneumoniae Affect Surfactant Trafficking and Secretion Due to Changes of Type II Cell Cytoskeleton Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 303 - 313. [Abstract] [Full Text] [PDF]

				H.L. Attalah, Y. Wu, M. Alaoui-El-Azher, F. Thouron, K. Koumanov, C. Wolf, L. Brochard, A. Harf, C. Delclaux, and L. Touqui Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury Eur. Respir. J., June 1, 2003; 21(6): 1040 - 1045. [Abstract] [Full Text] [PDF]

				A. M. Dukelow, S. Weicker, T. A. Karachi, H. M. Razavi, D. G. McCormack, M. G. Joseph, and S. Mehta Effects of Nebulized Diethylenetetraamine-NONOate in a Mouse Model of Acute Pseudomonas aeruginosa Pneumonia Chest, December 1, 2002; 122(6): 2127 - 2136. [Abstract] [Full Text] [PDF]

				T. A. Russo, L. A. Bartholomew, B. A. Davidson, J. D. Helinski, U. B. Carlino, P. R. Knight III, M. F. Beers, E. N. Atochina, R. H. Notter, and B. A. Holm Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L655 - L663. [Abstract] [Full Text] [PDF]

				T Whitehead and A S Slutsky The pulmonary physician in critical care * 7: Ventilator induced lung injury Thorax, July 1, 2002; 57(7): 635 - 642. [Abstract] [Full Text] [PDF]

				J. L. Malloy, R. A. W. Veldhuizen, and J. F. Lewis Effects of ventilation on the surfactant system in sepsis-induced lung injury J Appl Physiol, February 1, 2000; 88(2): 401 - 408. [Abstract] [Full Text] [PDF]